Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Hennekens, C, Buring, J, Sandercock, P, Collins, R, Peto, R
التنسيق:	Journal article
اللغة:	English
منشور في:	1989

مواد مشابهة

Aspirin and stroke.
حسب: Buring, J, وآخرون
منشور في: (1990)

ASPIRIN USE AND CHRONIC DISEASES
حسب: Hennekens, C, وآخرون
منشور في: (1990)

Aspirin in ischemic heart disease.
حسب: Hennekens, C, وآخرون
منشور في: (1992)

Low-dose aspirin for migraine prophylaxis.
حسب: Buring, J, وآخرون
منشور في: (1990)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
حسب: Baigent, C, وآخرون
منشور في: (2009)

Antioxidant vitamins, cancer, and cardiovascular disease - Reply
حسب: Hennekens, C, وآخرون
منشور في: (1996)

Antiplatelet agents in stroke prevention.
حسب: Peto, R
منشور في: (1988)

Aspirin in the primary prevention of vascular disease Reply
حسب: Baigent, C, وآخرون
منشور في: (2009)

Aspirin in the primary prevention of vascular disease Reply
حسب: Baigent, C, وآخرون
منشور في: (2009)

Prevention. Aspirin in primary prevention--good news and bad news.
حسب: Hennekens, C, وآخرون
منشور في: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
حسب: Hennekens, C, وآخرون
منشور في: (2012)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
حسب: Collins, R, وآخرون
منشور في: (1994)

TRIALS OF ANTIPLATELET THERAPY - REPLY
حسب: Baigent, C, وآخرون
منشور في: (1994)

Polypills with or without aspirin for primary prevention of cardiovascular disease
حسب: Mant, J, وآخرون
منشور في: (2021)

Role of aspirin in primary prevention of cardiovascular disease
حسب: Patrono, C, وآخرون
منشور في: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
حسب: VanWormer JJ, وآخرون
منشور في: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
حسب: Ying Xing, وآخرون
منشور في: (2019-07-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
منشور في: (2005-12-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
حسب: Randall S Stafford, وآخرون
منشور في: (2005-12-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
حسب: Guillaume Marquis‐Gravel, وآخرون
منشور في: (2024-02-01)

An overview of the British and American aspirin studies.
حسب: Hennekens, C, وآخرون
منشور في: (1988)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
حسب: Hennekens, C, وآخرون
منشور في: (2006)

PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
حسب: L. O. Minushkina
منشور في: (2017-12-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
حسب: Lozano R, وآخرون
منشور في: (2015-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
حسب: Yinong Chen, وآخرون
منشور في: (2021-09-01)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
حسب: Fernández-de-Bobadilla Jaime, وآخرون
منشور في: (2007-10-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
حسب: Sergio Coccheri
منشور في: (2017-04-01)

Antiplatelet treatment in primary and secondary stroke prevention in women.
حسب: Caso, V, وآخرون
منشور في: (2012)

Antiplatelet treatment in primary and secondary stroke prevention in women
حسب: Caso, V, وآخرون
منشور في: (2012)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
حسب: Mikkel B. Christensen, وآخرون
منشور في: (2021-06-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
حسب: Price, H, وآخرون
منشور في: (2009)

Aspirin for prevention of cancer and cardiovascular disease.
حسب: Rose, P, وآخرون
منشور في: (2011)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
حسب: Patrono, C, وآخرون
منشور في: (2010)

Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
حسب: Nischal N Hegde, وآخرون
منشور في: (2023-01-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
حسب: Eleni Giannopoulou, وآخرون
منشور في: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
حسب: Athena L. Huang, وآخرون
منشور في: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
حسب: Athena L. Huang, MD, وآخرون
منشور في: (2023-09-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
حسب: N. В. Perepech, وآخرون
منشور في: (2018-05-01)

Antiplatelets in secondary stroke prevention
حسب: Olga eShulga, وآخرون
منشور في: (2011-07-01)

Antioxidant vitamins--benefits not yet proved.
حسب: Hennekens, C, وآخرون
منشور في: (1994)